app_store_button

google_play_button

Device Banner Block-copy 894x1036

Astu lugude lõputusse maailma

Loe ja kuula

Daniel Faggella

The AI in Business Podcast is for non-technical business leaders who need to find AI opportunities, align AI capabilities with strategy, and deliver ROI.

Each week, Emerj research staff and journalists interview top AI executives from Fortune 2000 firms and unicorn startups - uncovering trends, use-cases, and best practices for practical AI adoption.

Visit our advertising page to learn more about reaching our executive audience of Fortune 2000 AI adopters: https://emerj.com/advertise

The AI in Business Podcast

Today's guest is Kun He, Lead Scientific Advisor at Bayer Crop Science. He joins Emerj Editorial Director Matthew DeMello to discuss how AI is transforming human talent and workforce development in agricultural manufacturing, balancing data-driven efficiency with the irreplaceable role of human gut instinct. Kun also explores practical takeaways, such as integrating genotyping and phenotyping data to accelerate crop-breeding workflows, empowering breeders to drive "step change" innovations, and treating AI as a co-pilot to check biases while prioritizing customer needs for blockbuster R&D outcomes. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast!

Transparency for AI Systems, Regulations, and Humans in Agricultural Manufacturing - with Kun He of Bayer

Today's guest is Chris Joynt, Director of Product Marketing at Securiti. Securiti is a leader in AI-powered data security, privacy, and governance across hybrid and multi-cloud environments. Chris joins Emerj Editorial Director Matthew DeMello to explore why trust in data remains the defining challenge for AI in financial services, and how institutions can modernize their architectures to enable safe, compliant, and scalable AI adoption. Chris also breaks down the practical workflows that reduce regulatory and cyber risk — mapping data flows, classifying unstructured data, preventing shadow AI — and shows how stronger governance ultimately accelerates ROI by enabling faster, more reliable AI deployment across the enterprise. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast! This episode is sponsored by Securiti.

Why Granular Visibility and Data Control Determines AI Success in Financial Services - with Chris Joynt of Securiti

Shefali Kakar, Global Head of PK Sciences and Oncology at Novartis, returns to the AI in Business podcast to discuss how AI is reshaping the earliest and most critical phases of drug development—where strategic investment decisions are made long before a clinical trial begins. Together with Emerj Editorial Director Matthew DeMello, Shefali explores how advanced modeling, in silico design, and patient data are creating a clearer picture of risk and return across R&D portfolios. She explains how pharmaceutical organizations are leveraging multi-factorial models to simulate safety, efficacy, and market potential—down to the molecular level. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast!

Rethinking Clinical Trials with Faster AI-Driven Decision Making - with Shefali Kakar of Novartis

Today's guest is Umesh Rustogi, General Manager of Dragon for Nursing, Microsoft Health & Life Sciences. Umesh joins Emerj Editorial Director Matthew DeMello to explore how nursing workflows are straining under documentation burden, and how ambient AI is being built — not repurposed — to fit the realities of frontline care. The conversation also examines practical workflow changes already emerging in the field, as well as early ROI signals to watch for. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast!

Human-Centered Innovation Driving Better Nurse Experiences - with Umesh Rustogi of Microsoft

Today's guest is Cody Barrow, CEO at EclecticIQ. EclecticIQ is a global cybersecurity leader specializing in threat intelligence technology. Cody joins Emerj Editorial Director Matthew DeMello to discuss how AI-driven analytics and automation are revolutionizing threat detection and response in enterprise cybersecurity. Barrow also highlights practical improvements in workflow automation, early threat identification, and measurable ROI through reduced breach risks and operational efficiency. This episode is sponsored by EclecticIQ. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast!

The Biggest Cybersecurity Challenges Facing Regulated and Mid-Market Sectors - with Cody Barrow of EclecticIQ

Today's guest is Dirk Michiels, CEO of Savaco. Savaco is a Belgium-based managed service provider specializing in hybrid cloud solutions, cybersecurity, and enterprise software deployment. Michiels joins Emerj Editorial Director Matthew DeMello to discuss the transformative role of hybrid cloud architectures in enterprise data and AI strategies. He also highlights how seamless integration, enhanced security protocols, and optimized deployment workflows lead to faster innovation and measurable ROI for modern organizations. This episode is sponsored by Xurrent. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast!

Overcoming Cloud Complexity in Mid Market Operations - with Dirk Michiels of Savaco

Today's guest is Meghna Punhani, Chief People Officer at Eightfold AI. Eightfold AI provides an AI-powered platform for talent management, helping organizations optimize hiring, internal mobility, and workforce development. Meghna joins Emerj Editorial Director Matthew DeMello to discuss how HR leaders can adopt AI responsibly to enhance workforce capabilities and drive strategic impact. She also shares practical insights on reengineering HR workflows, leveraging AI for candidate screening and internal mobility, and building human-centered ethical guardrails for AI implementation. This episode is sponsored by Eightfold AI. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast!

From Hiring to Growth and the Future of Workforce Strategy - with Meghna Punhani of Eightfold AI

Today's guest is Mathew Paruthickal, Global Head of Data Architecture, Utilization, and AI Engineering at Sanofi. Founded in 1973, Sanofi is a French multinational pharmaceutical and healthcare company. Sanofi works in the research, development, and manufacturing of pharmaceuticals and vaccines. Mathew joins Emerj Editorial Director Matthew DeMello to explore how life sciences organisations can move from isolated digital tools to orchestrated, interoperable systems and how engineering teams can bake in traceability, auditability, and human-in-the-loop governance from day one. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast!

"Waking Up" Data in Clinical Workflows with AI - with Mathew Paruthickal of Sanofi

Today's guest is Lauren Tulloch, Vice President and Managing Director at CCC (Copyright Clearance Center). CCC provides collective copyright licensing services for corporate and academic users of copyrighted materials, and, as one can imagine, the advent of AI has exposed a large number of businesses to copyright risks they've never considered before. Today, Lauren joins us to discuss where copyright exposure arises in financial services, from the growth of AI development to more commonplace employee use. With well over a decade at the company, Lauren dives into the urgent need for proactive copyright strategies in financial services, ensuring firms avoid litigation, regulatory scrutiny, and reputational damage, all while maximizing the value of AI. This episode is sponsored by CCC. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.

Copyright Risk in Financial Services and the Rise of Responsible AI – with Lauren Tulloch of CCC

Today's guest is Suvaleena Paul, Assistant Vice President and Senior Analyst in Fraud, Innovation, and Analysis at Bank of America. Suvaleena joins Emerj Editorial Director Matthew DeMello to discuss the integration of AI-driven technologies into fraud prevention workflows. She also shares practical insights on improving threat identification speed, fostering cross-team collaboration, and continuously refining AI models to maximize ROI and maintain regulatory compliance. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast!

Why False Positives Are Costing Banks More Than Fraud - with Suvaleena Paul of Bank of America

Today's guests are Melissa Easy, Vice President and General Manager of Clinical Technologies at IQVIA, and Tim Riely, Vice President of Clinical Data Analytics at IQVIA. They join Emerj Senior Editor Matthew DeMello on the program to talk about the current state of AI in life sciences and clinical trials. Throughout the episode, Melissa and Tim underscore the extent that clinical trials are changing thanks to data, and how life sciences will change as more people seek clinical trials as a form of alternative care. To discover more AI use cases, best practice guides, white papers, frameworks, and more, join Emerj Plus at emerj.com/p1.

The Impact of AI-Enhanced Clinical Trials on Patient Experiences - with Melissa Easy and Tim Riely of IQVIA

Loe ja kuula

Muud podcastid, mis võivad sulle meeldida ...